Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 18/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | FPR2 | P25090 | 1/20 | 0.35 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4018406 | 0.90 | CCR1 (0.42) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4018625 | 0.87 | CCR1 (0.53) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4016493 | 0.86 | CCR1 (0.39) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4019925 | 0.85 | CCR1 (0.40) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4018084 | 0.84 | LMNA (0.42) | CCR1 | |
| SCHEMBL4565941 | 0.84 | CCR1 (0.55) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4019875 | 0.84 | CCR1 (0.45) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4016533 | 0.84 | CCR1 (0.39) | CCR1 | |
| SCHEMBL4013644 | 0.83 | CCR1 (0.48) | CCR1CYP2C19KCNH2 | |
| SCHEMBL4316179 | 0.83 | CCR1 (0.43) | CCR1CYP2C19KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1691810-A4 | SUBSTITUTED PIPERAZINES | CHEMOCENTRYX INC (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-1691810-A1 | SUBSTITUTED PIPERAZINES | ChemoCentryx Inc (US) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005056015-A1 | SUBSTITUTED PIPERAZINES | CHEMOCENTRYX, INC. (US) | 2005-06-23 | — | — | WO | disclosed |